Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2002 3
2003 3
2004 4
2005 13
2006 8
2007 3
2008 2
2009 2
2010 5
2011 4
2012 10
2013 12
2014 8
2015 10
2016 9
2017 12
2018 13
2019 15
2020 7
2021 16
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Results by year
Filters applied: . Clear all
Page 1
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
Ueda K, Kumari R, Schwenger E, Wheat JC, Bohorquez O, Narayanagari SR, Taylor SJ, Carvajal LA, Pradhan K, Bartholdy B, Todorova TI, Goto H, Sun D, Chen J, Shan J, Song Y, Montagna C, Xiong S, Lozano G, Pellagatti A, Boultwood J, Verma A, Steidl U. Ueda K, et al. Among authors: steidl u. Cancer Cell. 2021 Apr 12;39(4):529-547.e7. doi: 10.1016/j.ccell.2021.02.006. Epub 2021 Mar 4. Cancer Cell. 2021. PMID: 33667384 Free PMC article.
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
Smith MA, Choudhary GS, Pellagatti A, Choi K, Bolanos LC, Bhagat TD, Gordon-Mitchell S, Von Ahrens D, Pradhan K, Steeples V, Kim S, Steidl U, Walter M, Fraser IDC, Kulkarni A, Salomonis N, Komurov K, Boultwood J, Verma A, Starczynowski DT. Smith MA, et al. Among authors: steidl u. Nat Cell Biol. 2019 May;21(5):640-650. doi: 10.1038/s41556-019-0314-5. Epub 2019 Apr 22. Nat Cell Biol. 2019. PMID: 31011167 Free PMC article.
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia.
Carvajal LA, Neriah DB, Senecal A, Benard L, Thiruthuvanathan V, Yatsenko T, Narayanagari SR, Wheat JC, Todorova TI, Mitchell K, Kenworthy C, Guerlavais V, Annis DA, Bartholdy B, Will B, Anampa JD, Mantzaris I, Aivado M, Singer RH, Coleman RA, Verma A, Steidl U. Carvajal LA, et al. Among authors: steidl u. Sci Transl Med. 2018 Apr 11;10(436):eaao3003. doi: 10.1126/scitranslmed.aao3003. Sci Transl Med. 2018. PMID: 29643228 Free PMC article.
Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal.
Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CP, Techner JM, Will B, Nerlov C, Steidl U, Manz MG, Schroeder T, Passegué E. Pietras EM, et al. Among authors: steidl u. Nat Cell Biol. 2016 Jun;18(6):607-18. doi: 10.1038/ncb3346. Epub 2016 Apr 25. Nat Cell Biol. 2016. PMID: 27111842 Free PMC article.
Transcriptional circuit dynamics in HSPCs.
Tatsumi G, Steidl U. Tatsumi G, et al. Among authors: steidl u. Blood. 2021 Oct 21;138(16):1382-1384. doi: 10.1182/blood.2021012452. Blood. 2021. PMID: 34673950 No abstract available.
Paul S. Frenette (1965-2021).
Bowman TV, Jamieson C, Steidl U, Stanley ER, Gritsman K, Wagner D, Manwani D, Trumpp A, Suda T, Ito K, Dawlaty M, Lucas D, Pinho S. Bowman TV, et al. Among authors: steidl u. Cell Stem Cell. 2021 Oct 7;28(10):1686-1689. doi: 10.1016/j.stem.2021.09.013. Cell Stem Cell. 2021. PMID: 34624230 No abstract available.
Paul S. Frenette (1965-2021).
Bowman TV, Jamieson C, Steidl U, Stanley ER, Gritsman K, Wagner D, Manwani D, Trumpp A, Suda T, Ito K, Dawlaty M, Lucas D, Pinho S. Bowman TV, et al. Among authors: steidl u. Cell. 2021 Sep 30;184(20):5073-5076. doi: 10.1016/j.cell.2021.08.034. Cell. 2021. PMID: 34597597 No abstract available.
Stem cell origins of JMML.
Sundaravel S, Steidl U. Sundaravel S, et al. Among authors: steidl u. J Exp Med. 2021 Feb 1;218(2):e20202152. doi: 10.1084/jem.20202152. J Exp Med. 2021. PMID: 33427877 Free PMC article.
Epigenetic Achilles' heel of AML.
Ueda K, Steidl U. Ueda K, et al. Among authors: steidl u. Nat Cancer. 2021 May;2(5):481-483. doi: 10.1038/s43018-021-00212-w. Nat Cancer. 2021. PMID: 35122022 No abstract available.
159 results